Oncology Nutrition Market to Grow with a CAGR of 8.41% through 2028
Increasing incidence of cancer and the recognition of nutritional
challenges in cancer patients are expected to drive the Global Oncology
Nutrition Market growth in the forecast period, 2024-2028.
According to TechSci Research report, “Oncology Nutrition Market – Global
Industry Size, Share, Trends, Competition Forecast & Opportunities,
2028”, the Global Oncology Nutrition Market stood at USD 2.14 billion in
2022 and is anticipated to grow with a CAGR of 8.41% in the forecast period,
2024-2028. This can be attributed to global outreach. The global oncology
nutrition market transcends geographical boundaries. Cancer is a worldwide
health concern, affecting individuals in both developed and developing
countries. As awareness of the importance of proper nutrition in cancer care
grows, the market's reach expands, creating opportunities for growth and
development in various regions.
Furthermore, collaboration between nutritionists, oncologists,
researchers, and the food industry is expected to increase. This
interdisciplinary approach will lead to more evidence-based nutritional
interventions and the development of innovative products that meet the specific
needs of cancer patients.
Browse over XX market data Figures spread through XX Pages and an
in-depth TOC on
"Global Oncology Nutrition Market.”
The onset of the COVID-19 pandemic brought the oncology nutrition market
into focus, despite significant disruptions to healthcare systems. For example,
a study published in May 2021 by Nutrition and Cancer concentrated on
establishing nutritional guidelines to manage and prevent complications in all
cancer patients during the COVID-19 pandemic. Cancer patients are particularly
vulnerable to illnesses due to weakened immune systems or the effects of
anticancer treatments. Additionally, an article published by the National
Library of Medicine in June 2021 highlighted the role of nutrition, vitamin and
mineral supplementation, and the microbiota in various phases of COVID-19, as
well as the significance of diet in susceptibility, prevention, and management
of COVID-19 among cancer patients. This underscored the need for comprehensive
nutritional guidance for all cancer patients during the pandemic. As COVID-19
cases decreased, the market gradually stabilized, and demand for oncology
nutrition returned to normal levels, indicating the pandemic's substantial
impact on the market during the forecast period.
The primary drivers behind the growth of the oncology nutrition market
include the increasing global prevalence of cancer and the introduction of
novel oncology nutrition products. According to an article by BioMed Central
Ltd in April 2022, Germany is expected to witness a 20% increase in new cancer
cases by 2030. Furthermore, as stated in the AACR Cancer Progress Report 2022,
the number of cancer survivors in the United States grew by over a million in
the past three years, reaching more than 18 million as of January 1, 2022. The
utilization of nutritional products during and after cancer treatment provides
the body with the ability to combat the disease and offers resilience against
the side effects of treatment, thereby driving market growth.
Additionally, government and private agencies play a pivotal role in
raising awareness and contributing to market growth. For instance, the 2022
update from the American Society of Clinical Oncology (ASCO) Cancer.Net
recommends a healthy diet, rich in fruits, vegetables, and whole grains, after
cancer treatment is completed. Moreover, the Agency for Healthcare Research and
Quality reported a high prevalence of malnutrition among adult cancer patients
in October 2021, with estimates ranging from 25% to 80% across different
patient populations. This increase in malnutrition among cancer patients is
expected to fuel demand for oncology nutrition, further boosting market growth
over the forecast period.
The Global Oncology Nutrition Market is segmented into cancer type,
nutrition, formula, distribution channel, end user, regional distribution, and
company.
Based on its cancer type, the lung cancer segment is expected to
experience growth throughout the study period due to several factors. These include
the global high prevalence of lung cancer, an increase in the use of
nutritional supplements for lung cancer patients, and a growing awareness of
the importance of incorporating nutritional supplements into one's diet. For
example, according to the Lung Cancer Fact 2022 report, lung cancer remains the
leading cause of cancer-related deaths worldwide. In the United States alone,
it was estimated that 236,740 individuals would be diagnosed with lung cancer
in 2022, with 1 in 16 people receiving a lung cancer diagnosis during their
lifetime (1 in 15 men and 1 in 17 women). With the rising number of cancer
patients, there is a growing recognition of the vital role nutrition plays in
bolstering the body's ability to combat disease and in providing the necessary
strength and stamina to endure the side effects of treatment. As a result, the
demand for oncology nutrition is expected to increase over the forecasted
period.
Based on region, North America is anticipated to experience growth in
the overall oncology nutrition market throughout the projected period. This can
be attributed to various factors, including the increasing prevalence of cancer
and the presence of advanced healthcare infrastructure, among other significant
drivers. For instance, the American Cancer Society's 2022 report estimates
approximately 1.9 million new cancer cases in the United States for the same
year. Additionally, initiatives by government bodies, new product launches, and
collaborations related to cancer nutrition supplements are contributing to
market expansion. For example, the "2022 Oncology Nutrition
Symposium" conducted by the Academy of Nutrition and Dietetics on June 20,
2022, addressed various aspects of oncology nutrition, encompassing research,
prevention, treatment, recovery, palliative care, and hospice.
Major companies operating in Global Oncology Nutrition Market
are:
- Abbott Laboratories Inc
- Nestle SA
- Fresenius Kabi AG
- B Braun SE
- Hormel Foods
Corporation
- Danone SA
- MEIJI Holdings Co Ltd
- Global Health Products,
Inc.
- Victus Inc
- Mead Johnson & Co
LLC
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“The global oncology nutrition market is poised for significant growth
and transformation, with emerging trends focusing on personalization,
nutrigenomics, digital health solutions, functional foods, cancer prevention,
sustainability, global accessibility, and collaborative research efforts. The
upcoming trends underscore the importance of nutrition in cancer care and
highlight the industry's commitment to improving the quality of life and
outcomes for individuals battling cancer. As these trends continue to evolve,
they promise to shape the future of oncology nutrition, offering hope and
support to cancer patients worldwide,” said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based management consulting firm.
“Oncology Nutrition Market By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and
Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer,
Others), By Nutrition (Enteral Nutrition, Parenteral Nutrition), By Formula
(Standard Formula, Elemental Formula, Specialized Formula), By Formula
(Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End User (Hospitals,
Homecare, Specialty Clinics), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential
of Global Oncology Nutrition Market and provides statistics & information
on market size, structure and future market growth. The report intends to
provide cutting-edge market intelligence and help decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges, and opportunities in
Global Oncology Nutrition Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email:
[email protected]
Website:
https://www.techsciresearch.com